- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02907255
Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery (VIGILANCE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients are at risk for respiratory depression in the perioperative period. The opioids used in both patient controlled analgesia (PCA) and epidural analgesia can cause respiratory depression. The progression of opioid side effects usually starts with sedation, respiratory depression follows and, if left uncorrected, this can lead to respiratory and then cardiac arrest and death. Sedation is a common side-effect, occurring in about 13% of patients and the incidence of respiratory depression varies depending on the precise definition used and the analgesia modality, but it has been reported to occur in about 1% of cases. If you continuously monitor patients with oximetry and capnography the incidence of respiratory depression has been shown to be much higher, as high as 12%8. The incidence of cardiac arrest and death from opioid overdose has been estimated at about 2 cases per 10, 0009. Given that the number of patients undergoing surgery annually is about 100 million worldwide, respiratory depression occurs between 1 and 12 million times and it results in about 20, 000 preventable deaths each year10. The troublesome aspect of this complication is that it often occurs in healthy patients where the family and clinical staff do not anticipate a bad outcome.
The problem of unexpected respiratory depression amongst patients treated with opioids is compounded by the challenge of dealing with obstructive sleep apnea patients in the perioperative period. Obstructive sleep apnea, characterized by the complete or partial obstruction of the upper airway during sleep, is not rare, with about 25% of the general population (and a greater proportion of the surgical population) being at risk for this condition. These patients are at even greater risk of perioperative respiratory events and consequently the guidelines from the American Society of Anesthesiology recommend continuous monitoring of these patients13,14. These guidelines are expert-based as no clinical trials have established the efficacy of continuous monitoring in this population.
These two problems (respiratory depression from opioids and obstructive sleep apnea) have caused significant logistic problems in hospitals as many institutions do not have the equipment to provide continuous monitoring of patients outside of the intensive care units and there is limited capacity in the critical care areas to monitor all the patients at risk.
The impact of respiratory depression can be mitigated if it is recognized early enough and appropriate actions are taken to resuscitate the patient. Early recognition of this complication depends on frequent and regular vital sign assessments by nursing staff.
he problem in many surgical wards is that nursing staff, particularly at night, are spread thin and patients can occasionally go several hours without being seen. In this a period a patient can spiral into trouble from sedation to respiratory depression and eventually into respiratory and cardiac arrest. Previously, cardiac monitoring with telemetry has been available and could be used for patients in the perioperative period. Although telemetry has been proven useful for some groups of patients (including those with an automated defibrillator that has fired, those with a prolonged QT interval and those with acute heart failure) this technology will only pick up cases of respiratory depression that progress into a cardiac event15.
Recently technology has become commercially available to continuously monitor pulse oximetry and notify clinical staff wirelessly via a paging system. The advantage of such a system is that clinicians can be notified immediately when a patient begins to decompensate from respiratory depression within enough time to initiate resuscitation before the patient progresses to respiratory or cardiac arrest. Another benefit of these systems is that patients at risk can be monitored on regular surgical wards without utilizing additional nursing staff. A recent literature search (of MEDLINE) that searched the concepts of respiratory monitoring in the perioperative period (using the MESH keywords: monitoring, oximetry, postoperative period and clinical trial) was conducted to see if there was evidence to support the use of these systems. Only a single study was identified in the search that specifically investigated the postoperative period, a before-after study on a 36-bed orthopedic ward found that a respiratory monitoring system was effective in reducing the need for rescue resuscitations and ICU transfers16. Although there is a Cochrane review on pulse oximetry for perioperative monitoring, this study focused only on intraoperative and recovery room monitoring and did not address monitoring of patients while on surgical wards17.
Given these promising results, a respiratory monitoring will be trialed on two surgical wards at the Juravinski Hospital in Hamilton, Ontario. In order to evaluate the impact of this technology the investigators designed a randomized controlled trial to determine if routine wireless respiratory monitoring for 72 hours of surgical patients on two surgical wards (that care for general surgery, urology and gynecology-oncology patients) reduces the need for rescue resuscitations - Naloxone resuscitation of opioid overdose, Code Blues (Cardio-respiratory arrests) and Intensive Care Unit (ICU) transfers. In addition, this study will also evaluate the risk factors for respiratory depression, the types and duration of respiratory alarms that occur and the impact on nursing workflow.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8V 1C3
- Hamilton Health Sciences-Juravinski Hospital Location
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All surgical admission to wards E4 and F4 at Juravinski Hospital in Hamilton, Ontario, Canada
Exclusion Criteria:
- Patient's refusal to be monitored
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Oximetry monitor
SpO2 ≤89% (heart rate) HR < 50 or > 120 |
Wireless respiratory monitoring system
Other Names:
|
|
NO_INTERVENTION: Standard of Care
• Standard care:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of rescue respiratory resuscitations and ICU Transfers
Time Frame: 3 days
|
Incidence of respiratory resuscitations and ICU transfers will be displayed as box plots and expressed as an odds ratio with 95% confidence intervals.
The primary outcome (respiratory resuscitations) will be collected through the existing hospital administrative systems: the Acute Pain Service records, Naloxone administration for respiratory depression and the Department of Critical Care records all Code Blues and ICU transfers.
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risks factors for alarm events
Time Frame: 3 days
|
Baseline patient information on all patients admitted to the study wards will be recorded including their demographics, past medical history and surgical details.
Cases of respiratory depression will be flagged by the monitoring system and a regression analysis will be used to determine the risk factors for respiratory events.
|
3 days
|
|
Monitor acceptance rate by patients
Time Frame: 3 days
|
Number of patients who accept or refuse to use the monitor will be recorded
|
3 days
|
|
Number of alarms per patient per day
Time Frame: 3 days
|
Alarm details will be downloaded from the servers for the respiratory monitoring systems.
Alarm types and duration and questionnaire results will be described with descriptive statistics.
|
3 days
|
|
Type (true or false alarms) and duration of alarms
Time Frame: 3 days
|
Alarm details will be downloaded from the servers for the respiratory monitoring systems.
Alarm types (true or false) and duration and questionnaire results will be described with descriptive statistics.
|
3 days
|
|
Response to alarm by nursing staff
Time Frame: 3 days
|
The impact the monitoring system has on nursing workflow will be quantified by a study questionnaire and by a workflow assessment tool developed by Cornell et al.18.
This behavioral-based list of 29 activities, that are mutually exclusive and comprehensive, will be modified to include items for responding to and documenting the respiratory alarms.
Questionnaire results will be described with descriptive statistics.
All nursing staff will fill out the questionnaire at the end of the study and the alarm documentation form will be filled out by each nurse that responds to a system alarm.
|
3 days
|
|
Impact on nursing workflow
Time Frame: 3 days
|
The impact on nursing workflow will be assessed with a questionnaire which assesses their subjective feedback regarding the reliability of the system, its ease of use and its impact on patient safety.
The nurse's responses to the alarms will be determined with an 'Alarm/Event Documentation Form' that is filled out by the bedside nurse.
- questionnaire results will be described with descriptive statistics.
All nursing staff will fill out the questionnaire at the end of the study and the alarm documentation form will be filled out by each nurse that responds to a system alarm.
|
3 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: James E Paul, MD, Associate Clinical Professor, Research Chair & Director of Acute Pain Service
Publications and helpful links
General Publications
- Popping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn EM. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth. 2008 Dec;101(6):832-40. doi: 10.1093/bja/aen300. Epub 2008 Oct 22.
- Syed S, Paul JE, Hueftlein M, Kampf M, McLean RF. Morphine overdose from error propagation on an acute pain service. Can J Anaesth. 2006 Jun;53(6):586-90. doi: 10.1007/BF03021849.
- Taenzer AH, Pyke JB, McGrath SP, Blike GT. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010 Feb;112(2):282-7. doi: 10.1097/ALN.0b013e3181ca7a9b. Erratum In: Anesthesiology. 2019 Dec 13;:null.
- Harsha P, Paul JE, Chong MA, Buckley N, Tidy A, Clarke A, Buckley D, Sirko Z, Vanniyasingam T, Walsh J, McGillion M, Thabane L. Challenges With Continuous Pulse Oximetry Monitoring and Wireless Clinician Notification Systems After Surgery: Reactive Analysis of a Randomized Controlled Trial. JMIR Med Inform. 2019 Oct 28;7(4):e14603. doi: 10.2196/14603.
- Paul JE, Chong MA, Buckley N, Harsha P, Shanthanna H, Tidy A, Buckley D, Clarke A, Young C, Wong T, Vanniyasingam T, Thabane L. Vital sign monitoring with continuous pulse oximetry and wireless clinical notification after surgery (the VIGILANCE pilot study)-a randomized controlled pilot trial. Pilot Feasibility Stud. 2019 Feb 26;5:36. doi: 10.1186/s40814-019-0415-8. eCollection 2019.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-581
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Depression
-
Children's Hospital Medical Center, CincinnatiCompletedOpioid Induced Respiratory DepressionUnited States
-
Hollister IncorporatedTerminatedRespiratory Failure | Ventilatory Depression | Respiratory DepressionUnited States
-
RespireRxDuke UniversityUnknownOpiate Induced Respiratory DepressionUnited States
-
Enalare Therapeutics Inc.National Institute on Drug Abuse (NIDA)Recruiting
-
Enalare Therapeutics Inc.Not yet recruitingRespiratory Depression
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedRespiratory Depression NeonatalDemocratic Republic of the Congo
-
NHS Greater Clyde and GlasgowCompletedRespiratory DepressionUnited Kingdom
-
University of Alabama at BirminghamWithdrawnRespiratory Depression
-
Leiden University Medical CenterU.S. Food and Drug Administration (FDA)RecruitingChronic Opioid Use | Opioid Induced Respiratory DepressionNetherlands
-
Erasme University HospitalUnknownVentilatory Depression | Oocyte Retrieval | Sedation, ConsciousBelgium
Clinical Trials on Oximetry monitor
-
Stanford UniversityWork of Breathing Study GroupCompletedAsthma | Copd | Respiratory Effort | Contactless Vital Sign MonitoringUnited States
-
University Health Network, TorontoCompleted
-
University of Wisconsin, MadisonAABB FoundationCompletedOxygen ConsumptionUnited States
-
Medline IndustriesClinimark, LLCCompletedHealthy | Arterial Oxygen SaturationUnited States
-
Medline IndustriesClinimark, LLCWithdrawn
-
Aga Khan UniversityBill and Melinda Gates FoundationCompletedHypoxemia | Severe PneumoniaPakistan
-
Kasr El Aini HospitalCompletedHyperventilation | Infratentorial Neoplasms | CraniotomyEgypt
-
University Hospital, ToursCompletedNeuromuscular Diseases in Children | Neuromuscular Diseases in InfantsFrance
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruitingObstructive Sleep ApneaBelgium